Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Beneficial Effects of the Treatment of Iron Deficiency on Clinical Condition, Left Ventricular Function, and Quality of Life in Patients With Chronic Heart Failure Publisher Pubmed



Mirdamadi A1 ; Arefeh A1 ; Garakyaraghi M2 ; Pourmoghadas A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Islamic Azad university, Najafabad Branch, Isfahan, Iran
  2. 2. Heart Failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, 81465-1148, Iran

Source: Acta Biomedica Published:2018


Abstract

Background: Anemia is now considered as an important contributing factor to the deterioration of chronic heart failure. The present study aimed to assess the effects of intravenous iron therapy on clinical condition, left ventricular function and also quality of life in patients who suffered of chronic heart failure and concomitant iron deficiency. Methods: In this clinical trial, 25 consecutive patients with concomitant chronic heart failure and iron deficiency referred to Shariati hospital in Isfahan, Iran in 2013. After initial clinical, laboratory, and echocardiography assessments, the patients administered 200 mg intravenous Iron per week until compensating iron deficit. Then, all study parameters were assessed again and compared to parameters before the therapeutic intervention. Results: The NYHA class showed a significant improvement after the therapeutic approach. The prevalence of heart failure-related edema was also significantly reduced from 60% before treatment to 48% after that (p = 0.036). The rate of hospitalization was considerably reduced from 42% to 16% (P < 0.001). Moreover, mean 6 minute walk test (6MWT) was increased from 155.18 m to 187.40 m (P < 0.001). Comparing Left Ventricular Ejection Fraction (LVEF) after treatment to figures before the test indicated a significant improvement in this parameter (27.5% versus 33.0%, P = 0.007). The treatment of iron deficiency in this group of subjects got a significant improvement in SF36 total score. Conclusion: In patients with chronic heart failure, the treatment of iron deficiency results in a marked improvement in functional status, ejection fraction, and also quality of life as well as a reduction in need to re-hospitalization, however renal function was deteriorated and thus more pay attention to renal function is necessary. © Mattioli 1885.
Related Docs
View other Related Docs
1. Cardiomyopathy in Thalassemia: Quick Review From Cellular Aspects to Diagnosis and Current Treatments, Lab Medicine (2020)
2. The Correlation Between the Cardiac and Hepatic Iron-Overload in Patients With Thalassemia Major Who Received Multiple Transfusion, Journal of Isfahan Medical School (2010)
3. Comparison of Iron Chelation Effects of Deferoxamine, Deferasirox, and Combination of Deferoxamine and Deferiprone on Liver and Cardiac T2* Mri in Thalassemia Maior, Caspian Journal of Internal Medicine (2017)
4. An Evaluation of Sensory Neural Hearing Loss in Thalassaemic Patients Treated With Desferrioxamine and Its Risk Factors, Journal of Research in Medical Sciences (2005)
5. The Effect of Astaxanthin Supplementation on Inflammatory Markers, Oxidative Stress Indices, Lipid Profile, Uric Acid Level, Blood Pressure, Endothelial Function, Quality of Life, and Disease Symptoms in Heart Failure Subjects, Trials (2024)
6. Cardioprotection Potential of Some Hydroxypyridine Iron Chelators Against H2o2-Induced H9c2 Cell Injury, Turkiye Klinikleri Cardiovascular Sciences (2017)
7. Combined Therapy of Silymarin and Desferrioxamine in Patients With Β-Thalassemia Major: A Randomized Double-Blind Clinical Trial, Fundamental and Clinical Pharmacology (2009)
8. Combination Effects of Seleniumand Coenzyme Q10 on Left Ventricular Systolic Function in Patients With Heart Failure, Iranian Heart Journal (2015)
Experts (# of related papers)
View all Related Experts
Davood Shafie (6)
Nizal Sarrafzadegan (4)
Other Related Docs
9. Vitamin D Supplementation Effects in Patients With Heart Failure, Journal of Isfahan Medical School (2010)
10. The Relation Between Body Iron Store and Ferritin, and Coronary Artery Disease, ARYA Atherosclerosis (2014)
11. T2-Weighted Cardiovascular Magnetic Resonance and Echocardiographic Arterial Elasticity Criteria for Monitoring Cardiac Siderosis in Patients With Beta-Thalassemia Major, Journal of Research in Medical Sciences (2022)
12. Correlation of N-Terminal Pro-B-Type Natriuretic Peptide Levels and Cardiac Magnetic Resonance Imaging T2∗ in Patients With Β-Thalassaemia Major, Blood Transfusion (2016)
13. Assessment of the Relationship Between Iron Overload Based on Cardiac T2* Mri and Fragmented Qrs in Beta-Thalassemia Major Patients, Shiraz E Medical Journal (2020)
14. Treatment of Chemotherapy Induced Anemia; a Randomized Clinical Trial to Compare Quality of Life in Patients Taking Intravenous Versus Oral Iron, Immunopathologia Persa (2021)
15. Evaluating the Safety and Efficacy of Silymarin in Β-Thalassemia Patients: A Review, Hemoglobin (2015)
16. Co-Administration of Silymarin and Deferoxamine Against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model, International Journal of Preventive Medicine (2014)
17. Metolazone Add-On Therapy in Heart Failure: A Cohort Study From Persian Registry of Cardiovascular Disease/Heart Failure (Prove/Hf), Critical Care Research and Practice (2021)
18. A Randomized Double-Blind, Placebo-Controlled Study of Therapeutic Effects of Silymarin in Β-Thalassemia Major Patients Receiving Desferrioxamine, European Journal of Haematology (2013)
19. Effects of Allopurinol on the Left Ventricular Ejection Fraction in Patients With Left Ventricular Failure, Journal of Isfahan Medical School (2007)
20. Biochemical Parameters of Iron Metabolism and Tg/Hdl-C Ratio in Patients With Coronary Artery Disease, Journal of Isfahan Medical School (2011)
21. Evaluation of the Prevalence and Determinants of Iron Deficiency Anemia in a Sample of Preschool-Aged Children in Isfahan City, Iran, Journal of Isfahan Medical School (2017)
22. Serum Myeloperoxidase Level in Patients With Chronic Heart Failure, Iranian Heart Journal (2015)
23. Efficacy and Safety of Iranian Made Deferasirox (Osveral®)In Iranian Major Thalassemic Patients With Transfusional Iron Overload: A One Year Prospective Multicentric Open-Label Non-Comparative Study, DARU, Journal of Pharmaceutical Sciences (2011)
24. Association of Digoxin With Mortality and Rehospitalization in Heart Failure Patients Treated With Beta-Blockers: Results From the Persian Heart Failure Patient Registry, ARYA Atherosclerosis (2022)
25. Is Red Cell Distribution Width a Reliable Marker for Cardiovascular Diseases? a Narrative Review, Cardiology in Review (2024)
26. Prevalence of Anemia According to Some Hematological Parameters Among Reproductive-Age Females in Kermanshah, Western Iran, Journal of Nutrition and Food Security (2019)
27. Explaining the Decline in Coronary Heart Disease Mortality Rate Using Impact Model: Estimation of the Changes in Risk Factors and Treatment Uptake in Iran Between 2007 and 2016, ARYA Atherosclerosis (2023)
28. The Effect of Combination Iron Chelating Agents on Reducing the Severity Grading of Heart and Liver Iron Overload in Β-Thalassemia Patients, Iranian Journal of Pediatric Hematology and Oncology (2019)
29. The Effect of Zinc and Selenium Supplements on the Prevalence of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized Clinical Trial Study; [:تأثیر مکمل های سلنیوم و روی بر رخداد فیبریلاسیون دهلیسی بعد از عمل جراحی پیوند عروق کرونر: یک مطالعه کارآزمایی بالینی تصادفی شده], Journal of Isfahan Medical School (2024)
30. Hypercoagulopathy and Serum “Natural Antithrombotic Factors” in Beta-Thalassemia Major, Journal of Isfahan Medical School (2008)
31. Evaluation of Iron Status by Serum Ferritin Level in Iranian Carriers of Beta Thalassemia Minor, International Journal for Vitamin and Nutrition Research (2008)
32. Survival Rate and Predictors of Mortality in Patients Hospitalised With Heart Failure: A Cohort Study on the Data of Persian Registry of Cardiovascular Disease (Prove), Postgraduate Medical Journal (2018)
33. A Randomized, Double-Blind Clinical Trial of the Three-Month Effect of Garlic Administration on Cardiac Outcomes in Patients With Heart Failure, ARYA Atherosclerosis (2022)
34. Novel Treatments of Hypertrophic Cardiomyopathy in Gdmt for Heart Failure: A State-Of-Art Review, Current Problems in Cardiology (2023)
35. The Effect of Simultaneous Administration of Zinc Sulfate and Ferrous Sulfate in the Treatment of Anemic Pregnant Women, Journal of Research in Medical Sciences (2005)
36. The Effect of Vitamin D Therapy in the Improvement of Cardiac Performance and Exercise Capacity in Patients With Heart Failure: A Double-Blind, Randomized, Placebo-Controlled Trial, ARYA Atherosclerosis (2021)
37. Influence of Average Annual Mean Serum Ferritin Levels on Left Ventricular Function in Patients With Β Thalassemia, Acta Medica Iranica (2020)
38. Prevalence Of, Association With, Severity Of, and Prognostic Role of Serum Hemoglobin Level in Acutely Decompensated Heart Failure Patients, BMC Cardiovascular Disorders (2023)
39. Effects of Iron on Vitamin D Metabolism: A Systematic Review, International Journal of Preventive Medicine (2016)
40. Correlation Between Myocardial Iron Overload Detected by Cmrt2∗ and Left Ventricular Function Assessed by Tissue Doppler Imaging in Patients With Thalassemia Major, Journal of Cardiovascular Echography (2022)